comparative effectiveness News
Most Popular comparative effectiveness Story
Reform passes House with pros, cons for pharma
Want pharma's good news first? The House Energy and Commerce Committee attached a provision for 12 years of biologic drug exclusivity to broader healthcare reform legislation. That's despite calls... Read more...
Latest Headlines
- August 13, 2009
- August 3, 2009
- July 31, 2009
- July 1, 2009
- June 16, 2009
- June 12, 2009
- April 14, 2009
- April 7, 2009
- February 17, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
